Despite the shrinking consumer wallet and harsh economic environment, healthcare company, GlaxoSmithKline Consumer Nigeria Plc, (GSK) grew its half-year 2019 net profit for the period ended 30th June, by 2.76percent to N372million from N362million in the corresponding period in 2018, while revenue g
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
